BlackRock’s Verrica Pharmaceuticals VRCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$29.9K Sell
5,647
-117,108
-95% -$621K ﹤0.01% 5008
2025
Q1
$543K Buy
122,755
+3,799
+3% +$16.8K ﹤0.01% 4328
2024
Q4
$833K Buy
118,956
+10,412
+10% +$72.9K ﹤0.01% 4215
2024
Q3
$1.57M Sell
108,544
-4,370
-4% -$63.4K ﹤0.01% 4015
2024
Q2
$8.23M Buy
112,914
+1,508
+1% +$110K ﹤0.01% 3436
2024
Q1
$6.6M Sell
111,406
-2,168
-2% -$128K ﹤0.01% 3504
2023
Q4
$8.31M Buy
113,574
+8,469
+8% +$620K ﹤0.01% 3417
2023
Q3
$4.08M Buy
105,105
+4,767
+5% +$185K ﹤0.01% 3674
2023
Q2
$5.79M Buy
100,338
+89,671
+841% +$5.17M ﹤0.01% 3591
2023
Q1
$693K Buy
10,667
+2,181
+26% +$142K ﹤0.01% 4370
2022
Q4
$233K Sell
8,486
-19,444
-70% -$535K ﹤0.01% 4724
2022
Q3
$816K Buy
27,930
+6,763
+32% +$198K ﹤0.01% 4465
2022
Q2
$407K Sell
21,167
-56,815
-73% -$1.09M ﹤0.01% 4749
2022
Q1
$6.32M Sell
77,982
-1,465
-2% -$119K ﹤0.01% 3752
2021
Q4
$7.28M Buy
79,447
+14,925
+23% +$1.37M ﹤0.01% 3774
2021
Q3
$8.07M Sell
64,522
-5,762
-8% -$720K ﹤0.01% 3713
2021
Q2
$7.94M Buy
70,284
+161
+0.2% +$18.2K ﹤0.01% 3664
2021
Q1
$10.6M Sell
70,123
-1,766
-2% -$268K ﹤0.01% 3475
2020
Q4
$8.28M Buy
71,889
+3,411
+5% +$393K ﹤0.01% 3400
2020
Q3
$5.3M Sell
68,478
-3,332
-5% -$258K ﹤0.01% 3462
2020
Q2
$7.91M Sell
71,810
-1,105
-2% -$122K ﹤0.01% 3252
2020
Q1
$7.97M Buy
72,915
+188
+0.3% +$20.5K ﹤0.01% 3066
2019
Q4
$11.6M Buy
72,727
+3,202
+5% +$509K ﹤0.01% 3129
2019
Q3
$10.3M Buy
69,525
+6,081
+10% +$897K ﹤0.01% 3163
2019
Q2
$7.37M Buy
63,444
+15,068
+31% +$1.75M ﹤0.01% 3346
2019
Q1
$5.23M Buy
48,376
+21,609
+81% +$2.34M ﹤0.01% 3357
2018
Q4
$2.18M Buy
26,767
+1,254
+5% +$102K ﹤0.01% 3603
2018
Q3
$4.15M Buy
+25,513
New +$4.15M ﹤0.01% 3510